BUY 1 GET 1 50% OFF
no code needed

every product, sitewide — no code, applied automatically at checkout

side-by-side research comparison

Epitalon vs GLP-3 RTA

Epitalon and GLP-3 RTA come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.

✓ both US-made · third-party tested · batch COA on every order

Last updated August 25, 2026

How do Epitalon and GLP-3 RTA differ?

Epitalon (Synthetic tetrapeptide) is catalogued under longevity & cellular research; GLP-3 RTA (Synthetic triple-agonist peptide) is catalogued under weight & metabolic research. Verve lists 5 reported research applications for Epitalon and 5 for GLP-3 RTA. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.

Epitalon compared with GLP-3 RTA across compound class, research area, supply format, purity standard, documentation, catalog price and stock.
fieldEpitalonGLP-3 RTA
compound classSynthetic tetrapeptideSynthetic triple-agonist peptide
research arealongevity & cellularweight & metabolic
reported research applications5 listed5 listed
supplied assingle compoundsingle compound
catalog sizes10mg · 50mg10mg · 20mg · 30mg
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
endotoxin-tested optionnot offeredavailable
co-formulated together innot co-formulatednot co-formulated
price from$50.49$142.99
availabilityout of stockin stock

Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.

What is Epitalon and what is GLP-3 RTA?

Epitalon is classified as Synthetic tetrapeptide; GLP-3 RTA as Synthetic triple-agonist peptide. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.

Epitalon

Synthetic tetrapeptide

Epitalon is a synthetic tetrapeptide with the sequence alanyl-glutamyl-aspartyl-glycine (Ala-Glu-Asp-Gly), developed as a short synthetic analog of a peptide fraction isolated from the pineal gland. It is a small, water-soluble peptide and one of the most frequently cited reference compounds in pineal-peptide and cellular-aging research literature.

full Epitalon profile →

GLP-3 RTA

Synthetic triple-agonist peptide

GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.

full GLP-3 RTA profile →

Which research models is each compound studied in?

Epitalon sits in longevity & cellular research and GLP-3 RTA in weight & metabolic research, so their listed models largely do not intersect. The table lists 5 reported research applications for Epitalon and 5 for GLP-3 RTA. Rows are per compound, not equivalences.

Reported research applications listed for Epitalon and for GLP-3 RTA. Entries are listed per compound; a shared row is not a claim that the two applications are equivalent.
Epitalon — reported research applicationsGLP-3 RTA — reported research applications
Telomerase-expression research modelsGLP-1, GIP, and glucagon receptor agonism research
Pineal-peptide and circadian-signaling researchcAMP and class B GPCR signaling research models
Chromatin and gene-regulation studiesComparative single-, dual-, and triple-agonist pharmacology studies
Cellular-senescence and replicative-aging research modelsMetabolic-pathway and nutrient-handling research models
Short-peptide stability and synthesis researchPeptide half-life, lipidation, and stability research

Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.

What sizes and prices does verve list for Epitalon and GLP-3 RTA?

Epitalon is listed from $50.49 and GLP-3 RTA from $142.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.

Catalog sizes, single-vial prices and stock status for Epitalon and GLP-3 RTA.
compoundsize listedpriceavailability
Epitalon10mg$50.49out of stock
Epitalon50mg$64.99out of stock
GLP-3 RTA10mg$142.99in stock
GLP-3 RTA20mg$242.99in stock
GLP-3 RTA30mg$328.99in stock
Epitalonout of stock
GLP-3 RTAfrom $142.99

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

shop the compounds →

Frequently asked questions about Epitalon and GLP-3 RTA

What is Epitalon?

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on a peptide fraction identified in the pineal gland. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is Epitalon studied for in research?

In in-vitro and pre-clinical research it is used as a reference compound in telomerase-expression, gene-regulation, cellular-senescence, and pineal-peptide signaling models. Verve makes no claims about use in humans or animals.

What is GLP-3 RTA?

GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is GLP-3 RTA studied for in research?

In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.